Label: CVS MAXIMUM REDNESS RELIEF- glycerin, naphazoline hci solution/ drops
- NDC Code(s): 51316-837-01
- Packager: CVS Pharmacy, Inc.
- Category: HUMAN OTC DRUG LABEL
- DEA Schedule: None
Drug Label Information
Updated December 23, 2023
If you are a consumer or patient please visit this version.
- Download DRUG LABEL INFO: PDF XML
- Official Label (Printer Friendly)
- Active ingredients
- PURPOSE
- INDICATIONS & USAGE
-
Warnings
For external use only
When using this product
• to avoid contamination, do not touch tip of container to any surface
• replace cap after using
• overuse may produce increased redness of the eye
• pupils may become enlarged temporarily
- DOSAGE & ADMINISTRATION
- OTHER SAFETY INFORMATION
- INACTIVE INGREDIENT
- PRINCIPAL DISPLAY PANEL
-
INGREDIENTS AND APPEARANCE
CVS MAXIMUM REDNESS RELIEF
glycerin, naphazoline hci solution/ dropsProduct Information Product Type HUMAN OTC DRUG Item Code (Source) NDC:51316-837 Route of Administration OPHTHALMIC Active Ingredient/Active Moiety Ingredient Name Basis of Strength Strength NAPHAZOLINE HYDROCHLORIDE (UNII: MZ1131787D) (NAPHAZOLINE - UNII:H231GF11BV) NAPHAZOLINE HYDROCHLORIDE 0.03 g in 100 mL GLYCERIN (UNII: PDC6A3C0OX) (GLYCERIN - UNII:PDC6A3C0OX) GLYCERIN 0.5 g in 100 mL Inactive Ingredients Ingredient Name Strength BORIC ACID (UNII: R57ZHV85D4) BENZALKONIUM CHLORIDE (UNII: F5UM2KM3W7) EDETATE DISODIUM (UNII: 7FLD91C86K) WATER (UNII: 059QF0KO0R) SODIUM BORATE (UNII: 91MBZ8H3QO) Packaging # Item Code Package Description Marketing Start Date Marketing End Date 1 NDC:51316-837-01 1 in 1 BOX 03/24/2023 1 15 mL in 1 BOTTLE, DROPPER; Type 0: Not a Combination Product Marketing Information Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date OTC Monograph Drug M018 03/24/2023 Labeler - CVS Pharmacy, Inc. (062312574) Registrant - KC Pharmaceuticals, Inc. (174450460) Establishment Name Address ID/FEI Business Operations KC Pharmaceuticals, Inc. 174450460 manufacture(51316-837) , pack(51316-837) , label(51316-837)